CN Patent

CN101668511A — 正常化睑板腺分泌的方法和化合物

Assigned to ACIEX Inc · Expires 2010-03-10 · 16y expired

What this patent protects

本发明提供了使睑板腺分泌正常化的无水化合物，和它的使用方法。本发明还进一步提供了治疗和/或预防干眼症的体征和/或症状的化合物和方法。

USPTO Abstract

本发明提供了使睑板腺分泌正常化的无水化合物，和它的使用方法。本发明还进一步提供了治疗和/或预防干眼症的体征和/或症状的化合物和方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101668511A
Jurisdiction
CN
Classification
—
Expires
2010-03-10
Drug substance claim
No
Drug product claim
No
Assignee
ACIEX Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.